Vicor director exercises options and sells shares
Vicor director Andrew D'Amico exercised 7,512 Non Qualified Stock Options on May 4, 2026 at strike prices of $33.9600 and $41.6100 per share, receiving 7,512 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vicor director Andrew D'Amico exercised 7,512 Non Qualified Stock Options on May 4, 2026 at strike prices of $33.9600 and $41.6100 per share, receiving 7,512 shares of common stock. On the same date he sold 7,512 shares in multiple open-market transactions at weighted average prices, including $244.2950 and $267.6200 per share, under a Rule 10b5-1 trading plan adopted on September 12, 2024.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non Qualified Stock Option | 4,596 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 2,916 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,596 | $33.96 | $156K |
| Exercise | Common Stock | 2,916 | $41.61 | $121K |
| Sale | Common Stock | 200 | $244.295 | $49K |
| Sale | Common Stock | 100 | $246.76 | $25K |
| Sale | Common Stock | 200 | $247.905 | $50K |
| Sale | Common Stock | 200 | $249.835 | $50K |
| Sale | Common Stock | 1,943 | $251.0759 | $488K |
| Sale | Common Stock | 1,469 | $252.2003 | $370K |
| Sale | Common Stock | 595 | $253.6082 | $151K |
| Sale | Common Stock | 868 | $254.353 | $221K |
| Sale | Common Stock | 1,337 | $255.4454 | $342K |
| Sale | Common Stock | 300 | $256.2733 | $77K |
| Sale | Common Stock | 200 | $257.195 | $51K |
| Sale | Common Stock | 100 | $267.62 | $27K |
Footnotes (14)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.2700 to $244.3200.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.7600 to $246.7600.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.8300 to $247.9800.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.7100 to $249.9600.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.7300 to $251.6100.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.7900 to $252.4800.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.9300 to $253.9100.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.9500 to $254.9300.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.0000 to $255.9900.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.0200 to $256.6500.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.1800 to $257.2100.
- F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.6200 to $267.6200.
- F14. Options expire 2 years from each date of vesting.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Non Qualified Stock Option financial
weighted average price financial
derivative security financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock option exercises did Andrew D'Amico report for VICR?
What type of options did Andrew D'Amico exercise in relation to VICR?
How many individual sale transactions did Andrew D'Amico report for VICR?
AI-generated analysis. How Rhea-AI works. Not financial advice.